Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for shorter weaning from invasive ventilation
NL-OMON58753Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Weaning failure comparing Levosimendan with Placebo / control (2 arms). Primary endpoint: Ventilator-free days to day 28. Started Sep 2025; status: recruiting.
02
Drugs
levosimendan
03
Conditions
Weaning failure
Beyond the preview
Go deeper on NL-OMON58753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58753.